Published in J Carcinog on March 24, 2011
Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol (2012) 2.97
The gut microbiome modulates colon tumorigenesis. MBio (2013) 2.45
Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer. Proc Natl Acad Sci U S A (2013) 1.64
Aryl Hydrocarbon Receptor Activation Down-Regulates IL-7 and Reduces Inflammation in a Mouse Model of DSS-Induced Colitis. Dig Dis Sci (2015) 1.50
Loss of Stromal IMP1 Promotes a Tumorigenic Microenvironment in the Colon. Mol Cancer Res (2015) 1.44
Structure of the gut microbiome following colonization with human feces determines colonic tumor burden. Microbiome (2014) 1.27
Targeted deletion of the metastasis-associated phosphatase Ptp4a3 (PRL-3) suppresses murine colon cancer. PLoS One (2013) 1.07
Host miR155 promotes tumor growth through a myeloid-derived suppressor cell-dependent mechanism. Cancer Res (2014) 1.06
Dextran sodium sulfate inhibits the activities of both polymerase and reverse transcriptase: lithium chloride purification, a rapid and efficient technique to purify RNA. BMC Res Notes (2013) 1.05
p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. World J Gastroenterol (2014) 1.02
Modeling colitis-associated cancer with azoxymethane (AOM) and dextran sulfate sodium (DSS). J Vis Exp (2012) 1.01
Diverse roles of STING-dependent signaling on the development of cancer. Oncogene (2015) 0.98
Increased dietary vitamin D suppresses MAPK signaling, colitis, and colon cancer. Cancer Res (2014) 0.97
Effects of fish oil supplementation on prostaglandins in normal and tumor colon tissue: modulation by the lipogenic phenotype of colon tumors. J Nutr Biochem (2017) 0.97
Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice. Carcinogenesis (2011) 0.95
Cancer in inflammatory bowel disease: lessons from animal models. Curr Opin Gastroenterol (2012) 0.93
NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr Biol (2015) 0.93
Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β-catenin signaling pathway. Toxicol Appl Pharmacol (2012) 0.92
Estrogen receptor-β protects against colitis-associated neoplasia in mice. Int J Cancer (2012) 0.92
Mouse models for colorectal cancer. Am J Cancer Res (2013) 0.91
Sporadic colon cancer murine models demonstrate the value of autoantibody detection for preclinical cancer diagnosis. Sci Rep (2013) 0.85
Nod-like receptors: key molecular switches in the conundrum of cancer. Front Immunol (2014) 0.85
The Msi Family of RNA-Binding Proteins Function Redundantly as Intestinal Oncoproteins. Cell Rep (2015) 0.84
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate. Cell Rep (2016) 0.84
O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms. J Mol Med (Berl) (2012) 0.83
A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth. J Cell Physiol (2015) 0.83
IL-32α suppresses colorectal cancer development via TNFR1-mediated death signaling. Oncotarget (2015) 0.82
Novel insights into Notum and glypicans regulation in colorectal cancer. Oncotarget (2015) 0.82
Characterization of dextran sodium sulfate-induced inflammation and colonic tumorigenesis in Smad3(-/-) mice with dysregulated TGFβ. PLoS One (2013) 0.82
C-kit signaling promotes proliferation and invasion of colorectal mucinous adenocarcinoma in a murine model. Oncotarget (2015) 0.81
Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role? World J Gastroenterol (2014) 0.81
American ginseng significantly reduced the progression of high-fat-diet-enhanced colon carcinogenesis in Apc (Min/+) mice. J Ginseng Res (2015) 0.80
Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses. Oncotarget (2015) 0.80
The IL-33/ST2 pathway contributes to intestinal tumorigenesis in humans and mice. Oncoimmunology (2015) 0.80
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer. Biomaterials (2016) 0.80
Chemopreventive effects of Strobilanthes crispus leaf extract on azoxymethane-induced aberrant crypt foci in rat colon. Sci Rep (2015) 0.79
Glutamine supplementation attenuates ethanol-induced disruption of apical junctional complexes in colonic epithelium and ameliorates gut barrier dysfunction and fatty liver in mice. J Nutr Biochem (2015) 0.78
Stool phospholipid signature is altered by diet and tumors. PLoS One (2014) 0.78
CD80-CD28 signaling controls the progression of inflammatory colorectal carcinogenesis. Oncotarget (2015) 0.78
Loss of sulfiredoxin renders mice resistant to azoxymethane/dextran sulfate sodium-induced colon carcinogenesis. Carcinogenesis (2013) 0.78
Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer. Oncogene (2014) 0.78
Inhibition of autophagy exerts anti-colon cancer effects via apoptosis induced by p53 activation and ER stress. BMC Cancer (2015) 0.77
EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis. Oncogene (2017) 0.77
Acute blockade of IL-25 in a colitis associated colon cancer model leads to increased tumor burden. Sci Rep (2016) 0.77
DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis. Oncogene (2015) 0.77
Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis. mSphere (2015) 0.77
Chemopreventive effects of nobiletin and its colonic metabolites on colon carcinogenesis. Mol Nutr Food Res (2015) 0.77
Identification of gene expression changes from colitis to CRC in the mouse CAC model. PLoS One (2014) 0.77
Stromal Hedgehog signalling is downregulated in colon cancer and its restoration restrains tumour growth. Nat Commun (2016) 0.77
Simultaneous follow-up of mouse colon lesions by colonoscopy and endoluminal ultrasound biomicroscopy. World J Gastroenterol (2013) 0.77
Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway. PLoS One (2015) 0.77
Colon carcinogenesis in wild type and immune compromised mice after treatment with azoxymethane, and azoxymethane with dextran sodium sulfate. Mol Carcinog (2015) 0.77
The Aryl Hydrocarbon Receptor is a Repressor of Inflammation-associated Colorectal Tumorigenesis in Mouse. Ann Surg (2016) 0.76
The epigenetic effects of aspirin: the modification of histone H3 lysine 27 acetylation in the prevention of colon carcinogenesis in azoxymethane- and dextran sulfate sodium-treated CF-1 mice. Carcinogenesis (2016) 0.76
The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells. Oncogene (2016) 0.76
Inflammation as a driver and vulnerability of KRAS mediated oncogenesis. Semin Cell Dev Biol (2016) 0.76
Epidermal growth factor is a critical regulator of the cytokine IL-33 in intestinal epithelial cells. Br J Pharmacol (2016) 0.76
Nrf2-dependent suppression of azoxymethane/dextran sulfate sodium-induced colon carcinogenesis by the cinnamon-derived dietary factor cinnamaldehyde. Cancer Prev Res (Phila) (2015) 0.76
The MYC 3' Wnt-Responsive Element Drives Oncogenic MYC Expression in Human Colorectal Cancer Cells. Cancers (Basel) (2016) 0.76
Alkaline ceramidase 3 deficiency aggravates colitis and colitis-associated tumorigenesis in mice by hyperactivating the innate immune system. Cell Death Dis (2016) 0.76
Non-invasive assessment of the efficacy of new therapeutics for intestinal pathologies using serial endoscopic imaging of live mice. J Vis Exp (2015) 0.76
Assessment of murine colorectal cancer by micro-ultrasound using three dimensional reconstruction and non-linear contrast imaging. Mol Ther Methods Clin Dev (2016) 0.75
Palmatine from Mahonia bealei attenuates gut tumorigenesis in ApcMin/+ mice via inhibition of inflammatory cytokines. Mol Med Rep (2016) 0.75
The Mbd4 DNA glycosylase protects mice from inflammation-driven colon cancer and tissue injury. Oncotarget (2016) 0.75
Predicting the progress of colon cancer by DNA methylation markers of the p16 gene in feces - Evidence from an animal model. Genet Mol Biol (2013) 0.75
A novel model of colitis-associated cancer in SAMP1/YitFc mice with Crohn's disease-like ileitis. PLoS One (2017) 0.75
Confocal foveated endomicroscope for the detection of esophageal carcinoma. Biomed Opt Express (2015) 0.75
Colorectal cancer models for novel drug discovery. Expert Opin Drug Discov (2015) 0.75
Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis. Oncotarget (2016) 0.75
Gingko biloba extract (Ginaton) ameliorates dextran sulfate sodium (DSS)-induced acute experimental colitis in mice via reducing IL-6/STAT3 and IL-23/IL-17. Int J Clin Exp Med (2015) 0.75
Critical role of PepT1 in promoting colitis-associated cancer and therapeutic benefits of the anti-inflammatory PepT1-mediated tripeptide KPV in a murine model. Cell Mol Gastroenterol Hepatol (2016) 0.75
Thrombospondin-1 in a Murine Model of Colorectal Carcinogenesis. PLoS One (2015) 0.75
From the Cover: PhIP/DSS-Induced Colon Carcinogenesis in CYP1A-Humanized Mice and the Possible Role of Lgr5+ Stem Cells. Toxicol Sci (2016) 0.75
The Pil3 pilus of Streptococcus gallolyticus binds to intestinal mucins and to fibrinogen. Gut Microbes (2016) 0.75
The role of Pygo2 for Wnt/ß-catenin signaling activity during intestinal tumor initiation and progression. Oncotarget (2016) 0.75
AOM/DSS Model of Colitis-Associated Cancer. Methods Mol Biol (2016) 0.75
Mouse models for the discovery of colorectal cancer driver genes. World J Gastroenterol (2016) 0.75
iRGD-functionalized PEGylated nanoparticles for enhanced colon tumor accumulation and targeted drug delivery. Nanomedicine (Lond) (2017) 0.75
Enhanced Therapeutic Treatment of Colorectal Cancer Using Surface-Modified Nanoporous Acupuncture Needles. Sci Rep (2017) 0.75
CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation. Oncogene (2017) 0.75
Inhibition of TRPM7 suppresses cell proliferation of colon adenocarcinoma in vitro and induces hypomagnesemia in vivo without affecting azoxymethane-induced early colon cancer in mice. Cell Commun Signal (2017) 0.75
Mechanisms of colitis-accelerated colon carcinogenesis and its prevention with the combination of aspirin and curcumin: Transcriptomic analysis using RNA-seq. Biochem Pharmacol (2017) 0.75
Modeling of Patient Derived Xenografts in Colorectal Cancer. Mol Cancer Ther (2017) 0.75
Dietary Phenethyl Isothiocyanate Protects Mice from Colitis Associated Colon Cancer. Int J Mol Sci (2017) 0.75
Extract from mango mistletoes Dendrophthoe pentandra ameliorates TNBS-induced colitis by regulating CD4+ T cells in mesenteric lymph nodes. BMC Complement Altern Med (2017) 0.75
Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice. Oncotarget (2017) 0.75
Dietary Heme Induces Gut Dysbiosis, Aggravates Colitis, and Potentiates the Development of Adenomas in Mice. Front Microbiol (2017) 0.75
Cancer-related inflammation. Nature (2008) 34.21
Immunity, inflammation, and cancer. Cell (2010) 28.27
Lessons from hereditary colorectal cancer. Cell (1996) 25.73
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell (2004) 15.82
Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc Natl Acad Sci U S A (1993) 10.82
Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature (1983) 9.28
Induction of tumors in mice by genomic hypomethylation. Science (2003) 8.86
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Nuclear receptors and lipid physiology: opening the X-files. Science (2001) 8.76
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med (2000) 7.54
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell (1996) 7.46
The carcinogenic action of 4-aminodiphenyl and 3:2'-dimethyl-4-amino-diphenyl. Br J Ind Med (1952) 6.91
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell (1995) 6.69
Tumour necrosis factor and cancer. Nat Rev Cancer (2009) 6.27
PPARgamma : a nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem (2001) 5.85
Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest (2008) 5.26
Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev (1996) 5.20
Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol (2004) 5.12
TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity (2004) 4.48
Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs (1999) 4.32
Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology (2003) 4.10
Molecular diagnosis of familial adenomatous polyposis. N Engl J Med (1993) 4.07
Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol (2004) 4.00
Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology (2007) 3.99
An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat Protoc (2007) 3.81
A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci (2003) 3.79
The ras protein family: evolutionary tree and role of conserved amino acids. Biochemistry (1991) 3.38
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest (2008) 3.17
TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev (2006) 3.14
Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification. Mol Pharmacol (2002) 2.94
TERT promotes epithelial proliferation through transcriptional control of a Myc- and Wnt-related developmental program. PLoS Genet (2007) 2.84
Promoting effect of bile acids on colon carcinogenesis after intrarectal instillation of N-methyl-N'-nitro-N-nitrosoguanidine in rats. J Natl Cancer Inst (1974) 2.79
Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev (2003) 2.76
Role of transforming growth factor-beta superfamily signaling pathways in human disease. Biochim Biophys Acta (2008) 2.72
Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in mice. Gastroenterology (2003) 2.65
Mouse models of inflammatory bowel disease. Adv Drug Deliv Rev (2007) 2.42
The IKK/NF-kappaB activation pathway-a target for prevention and treatment of cancer. Cancer Lett (2004) 2.41
In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy. Gut (2005) 2.30
Mouse models for the study of colon carcinogenesis. Carcinogenesis (2008) 2.10
Aberrant crypts: putative preneoplastic foci in human colonic mucosa. Cancer Res (1991) 2.06
Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut (1996) 2.06
Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. Cancer Res (1999) 2.01
Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res (2002) 2.00
Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis (2000) 1.95
Colitis-associated colorectal cancer driven by T-bet deficiency in dendritic cells. Cancer Cell (2009) 1.95
Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology (2005) 1.91
Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Gastroenterology (2008) 1.88
Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies. Gastroenterology (2007) 1.83
Ligands for peroxisome proliferator-activated receptors alpha and gamma inhibit chemically induced colitis and formation of aberrant crypt foci in rats. Cancer Res (2001) 1.80
Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol Cell Biol (2004) 1.77
IFNgamma-dependent, spontaneous development of colorectal carcinomas in SOCS1-deficient mice. J Exp Med (2006) 1.76
Suppressor of cytokine signaling 3 (SOCS3) limits damage-induced crypt hyper-proliferation and inflammation-associated tumorigenesis in the colon. Oncogene (2007) 1.75
Gene mutations and altered gene expression in azoxymethane-induced colon carcinogenesis in rodents. Cancer Sci (2004) 1.75
Role of Toll-like receptors in gastrointestinal malignancies. Oncogene (2008) 1.69
Strain differences in the susceptibility to azoxymethane and dextran sodium sulfate-induced colon carcinogenesis in mice. Carcinogenesis (2005) 1.65
Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol (1991) 1.64
The significance of aberrant crypt foci in understanding the pathogenesis of colon cancer. Toxicol Lett (2000) 1.59
Suppression of NF-kappaB activity by sulfasalazine is mediated by direct inhibition of IkappaB kinases alpha and beta. Gastroenterology (2000) 1.56
A new ligand for the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), GW7845, inhibits rat mammary carcinogenesis. Cancer Res (1999) 1.50
CARCINOGENIC EFFECTS OF CYCAD MEAL AND CYCASIN, METHYLAZOXYMETHANOL GLYCOSIDE, IN RATS AND EFFECTS OF CYCASIN IN GERMFREE RATS. Fed Proc (1965) 1.47
Dysplasia and carcinoma development in a repeated dextran sulfate sodium-induced colitis model. J Gastroenterol Hepatol (2002) 1.41
Role of cyclooxygenase-2 in colorectal cancer. Cancer Metastasis Rev (2004) 1.41
Frequent mutations of the beta-catenin gene in mouse colon tumors induced by azoxymethane. Carcinogenesis (2000) 1.39
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer (2005) 1.39
Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine. Cancer Res (1973) 1.37
Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis. Carcinogenesis (2000) 1.36
Beta-catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res (1998) 1.36
Morphogenesis of chemically induced neoplasms of the colon and small intestine in rats. Lab Invest (1974) 1.36
Activation of PPARgamma inhibits cell growth and induces apoptosis in human gastric cancer cells. FEBS Lett (1999) 1.35
Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. Comp Med (2000) 1.30
Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis. Cancer Res (2000) 1.28
Myc goes global: new tricks for an old oncogene. Cancer Res (2007) 1.27
Phenotypic and genotypic characteristics of aberrant crypt foci in human colorectal mucosa. Hum Pathol (1997) 1.26
Colon cancer and the immune system: the role of tumor invading T cells. World J Gastroenterol (2006) 1.24
Inhibition of intestinal polyposis with reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression. Mol Cancer Res (2007) 1.24
Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. Int J Cancer (2009) 1.24
Classification of aberrant crypt foci and microadenomas in human colon. Cancer Epidemiol Biomarkers Prev (1993) 1.23
Identification of mucin-depleted foci in the unsectioned colon of azoxymethane-treated rats: correlation with carcinogenesis. Cancer Res (2003) 1.23
Azoxymethane is a genetic background-dependent colorectal tumor initiator and promoter in mice: effects of dose, route, and diet. Toxicol Sci (2005) 1.21
NF-kappaB regulates netrin-1 expression and affects the conditional tumor suppressive activity of the netrin-1 receptors. Gastroenterology (2008) 1.19
Mouse models for colorectal cancer. Oncogene (1999) 1.19
Sequential and morphological analyses of aberrant crypt foci formation in mice of differing susceptibility to azoxymethane-induced colon carcinogenesis. Carcinogenesis (2000) 1.18
Differential effects of CYP2E1 status on the metabolic activation of the colon carcinogens azoxymethane and methylazoxymethanol. Cancer Res (2001) 1.17
Histogenesis and growth pattern of 1,2-dimethylhydrazine-induced rat colon adenocarcinoma. Cancer Res (1976) 1.17
Beta-Catenin mutations in a mouse model of inflammation-related colon carcinogenesis induced by 1,2-dimethylhydrazine and dextran sodium sulfate. Cancer Sci (2005) 1.17
TGF-beta as a T cell regulator in colitis and colon cancer. Cytokine Growth Factor Rev (2005) 1.17
Tumor formation in a mouse model of colitis-associated colon cancer does not require COX-1 or COX-2 expression. Carcinogenesis (2010) 1.15
Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression. Proc Natl Acad Sci U S A (2009) 1.13
Sequential analysis of morphological and biological properties of beta-catenin-accumulated crypts, provable premalignant lesions independent of aberrant crypt foci in rat colon carcinogenesis. Cancer Res (2001) 1.12
Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut (1998) 1.11
Disease model: familial adenomatous polyposis. Trends Mol Med (2001) 1.10
Differential expression, distribution, and function of PPAR-gamma in the proximal and distal colon. Physiol Genomics (2007) 1.09
Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol (2003) 1.07
Cyclooxygenase-2-dependent and -independent inhibition of proliferation of colon cancer cells by 5-aminosalicylic acid. Biochem Pharmacol (2007) 1.06
Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology (Bethesda) (2008) 1.06
Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J Clin Invest (1991) 1.04
Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene. J Biol Chem (2000) 1.04
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: a randomized trial. Ann Intern Med (2007) 5.62
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. Am J Gastroenterol (2010) 3.32
The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut (2007) 3.15
Cost-effectiveness of colorectal cancer screening with computed tomography colonography: the impact of not reporting diminutive lesions. Cancer (2007) 2.38
Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med (2006) 2.26
Computed tomographic colonography to screen for colorectal cancer, extracolonic cancer, and aortic aneurysm: model simulation with cost-effectiveness analysis. Arch Intern Med (2008) 2.24
Bilateral consecutive rupture of the quadriceps tendon in a man with BstUI polymorphism of the COL5A1 gene. Knee Surg Sports Traumatol Arthrosc (2009) 2.15
Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol (2009) 2.09
Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res (2008) 1.70
Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes. BMC Med (2011) 1.69
Glial fibrillary acidic protein as an early marker of hepatic stellate cell activation in chronic and posttransplant recurrent hepatitis C. Liver Transpl (2008) 1.65
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure. Am J Gastroenterol (2005) 1.60
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors. Clin Cancer Res (2004) 1.55
Cost effectiveness of colonoscopy, based on the appropriateness of an indication. Clin Gastroenterol Hepatol (2008) 1.48
Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev (2009) 1.43
Helicobacter pylori management in non-steroidal anti-inflammatory drug therapy patients in primary care. Intern Emerg Med (2011) 1.40
Liver vitamin D receptor, CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with nonalcoholic steatohepatitis or hepatitis C virus. Hepatology (2012) 1.34
Histopathology of the supraspinatus tendon in rotator cuff tears. Am J Sports Med (2007) 1.29
Intratumoural FOXP3-positive regulatory T cells are associated with adverse prognosis in radically resected gastric cancer. Eur J Cancer (2008) 1.27
Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma. Cancer Res (2006) 1.22
Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome. Epigenetics (2011) 1.20
Phenotypic and genotypic Helicobacter pylori clarithromycin resistance and therapeutic outcome: benefits and limits. J Antimicrob Chemother (2009) 1.16
Prevalence of primary clarithromycin resistance in Helicobacter pylori strains over a 15 year period in Italy. J Antimicrob Chemother (2007) 1.16
Histologic risk factors and clinical outcome in colorectal malignant polyp: a pooled-data analysis. Dis Colon Rectum (2005) 1.16
Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol (2009) 1.15
DNA vaccines: developing new strategies against cancer. J Biomed Biotechnol (2010) 1.12
Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer. Epigenetics (2011) 1.12
Bleeding peptic ulcer in the elderly: risk factors and prevention strategies. Drugs Aging (2007) 1.10
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approaches. Cancer Res (2007) 1.10
Gastric anisakiasis: do not forget the clinical history! J Gastrointestin Liver Dis (2010) 1.09
Helicobacter pylori eradication with either 7-day or 10-day triple therapies, and with a 10-day sequential regimen. Can J Gastroenterol (2006) 1.07
Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond. World J Gastrointest Oncol (2010) 1.04
GFAP expression in the liver as an early marker of stellate cells activation. Ital J Anat Embryol (2006) 1.02
Reelin expression in human prostate cancer: a marker of tumor aggressiveness based on correlation with grade. Mod Pathol (2007) 1.02
Adenocarcinoma of the ileoanal pouch anastomosis: an emerging complication? Int J Colorectal Dis (2003) 1.02
Primary low-grade and high-grade gastric MALT-lymphoma presentation. J Clin Gastroenterol (2010) 1.01
A combined analytical approach reveals novel EXT1/2 gene mutations in a large cohort of Italian multiple osteochondromas patients. Genes Chromosomes Cancer (2007) 1.01
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome. Int J Cancer (2010) 1.01
Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther (2008) 1.00
Small and diminutive polyps detected at screening CT colonography: a decision analysis for referral to colonoscopy. AJR Am J Roentgenol (2008) 1.00
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med (2013) 0.99
Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother (2015) 0.99
Effect of ovariectomy on the proliferative capacity of intrahepatic rat cholangiocytes. Gastroenterology (2002) 0.97
Aberrant Keap1 methylation in breast cancer and association with clinicopathological features. Epigenetics (2012) 0.97
Mouse monoclonal antibodies in biological research: strategies for high-throughput production. Biotechnol Lett (2008) 0.96
Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Cell Cycle (2013) 0.96
Ileal FGF15 contributes to fibrosis-associated hepatocellular carcinoma development. Int J Cancer (2014) 0.95
Light microscopic histology of supraspinatus tendon ruptures. Knee Surg Sports Traumatol Arthrosc (2007) 0.95
Bacterial translocation and intestinal morphological findings in jaundiced rats. Dig Dis Sci (2002) 0.95
Clinical management of small (6- to 9-mm) polyps detected at screening CT colonography: a cost-effectiveness analysis. AJR Am J Roentgenol (2008) 0.95
Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Lett (2007) 0.93
The RELN locus in Alzheimer's disease. J Alzheimers Dis (2008) 0.91
Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products. Diagn Mol Pathol (2006) 0.90
Association of promoter methylation of VGF and PGP9.5 with ovarian cancer progression. PLoS One (2013) 0.90
Claritromycin resistance and Helicobacter pylori genotypes in Italy. J Microbiol (2006) 0.89
Revascularization and remodelling of pancreatic islets grafted under the kidney capsule. J Anat (2007) 0.89
Computed tomography enteroclysis in comparison with ileoscopy in patients with Crohn's disease. Int J Colorectal Dis (2002) 0.88
Endoscopic findings in patients with upper gastrointestinal bleeding clinically classified into three risk groups prior to endoscopy. World J Gastroenterol (2008) 0.88
HIC1 promoter methylation and 17p13.3 allelic loss in invasive ductal carcinoma of the breast. Cancer Lett (2005) 0.87
Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol (2003) 0.87
Evaluation of microRNA-10b prognostic significance in a prospective cohort of breast cancer patients. Mol Cancer (2014) 0.86
Ursodeoxycholic acid improves muscle contractility and inflammation in symptomatic gallbladders with cholesterol gallstones. Gut (2006) 0.86
Impact of computer-aided detection on the cost-effectiveness of CT colonography. Radiology (2009) 0.86
Treatment of low-grade gastric MALT-lymphoma unresponsive to Helicobacter pylori therapy: a pooled-data analysis. Med Oncol (2009) 0.86
Hypovitaminosis D is independently associated with metabolic syndrome in obese patients. PLoS One (2013) 0.85
Cyclic antibiotic therapy for diverticular disease: a critical reappraisal. J Gastrointestin Liver Dis (2010) 0.85
High specificity of quantitative methylation-specific PCR analysis for MGMT promoter hypermethylation detection in gliomas. J Biomed Biotechnol (2009) 0.84
Genetic and epigenetic analysis of erbB signaling pathway genes in lung cancer. J Thorac Oncol (2010) 0.84
Caveolin-1 expression in human breast lobular cancer progression. Mod Pathol (2008) 0.84
Immunohistochemistry and differential diagnosis of a solitary flat laryngeal xanthoma: a case report. In Vivo (2007) 0.84
Application of electroporation in DNA vaccination protocols. Curr Gene Ther (2010) 0.84
COX-2 expression of ampullary carcinoma: correlation with different histotypes and clinicopathological parameters. Virchows Arch (2006) 0.83
Differential modulation of Ku70/80 DNA-binding activity in a patient with multiple basal cell carcinomas. J Invest Dermatol (2003) 0.83
Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors. Genes Chromosomes Cancer (2012) 0.83
Relevance of interleukin-1 receptor antagonist intron-2 polymorphism in ischemic stroke. Cerebrovasc Dis (2003) 0.83
Matrix metalloproteinase-10 expression is induced during hepatic injury and plays a fundamental role in liver tissue repair. Liver Int (2013) 0.83
Appropriateness of upper-GI endoscopy: an Italian survey on behalf of the Italian Society of Digestive Endoscopy. Gastrointest Endosc (2007) 0.83
Appropriateness guidelines and predictive rules to select patients for upper endoscopy: a nationwide multicenter study. Am J Gastroenterol (2009) 0.83
Electroporation in DNA vaccination protocols against cancer. Curr Drug Metab (2013) 0.82
Relationship between beta-catenin expression and epithelial cell proliferation in gastric mucosa with intestinal metaplasia. World J Gastroenterol (2005) 0.82
COX-2 localization within plasma membrane caveolae-like structures in human lobular intraepithelial neoplasia of the breast. Virchows Arch (2007) 0.82